Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 16,103 $ 8,207
Restricted cash 20,894  
Short-term marketable securities 5,124 3,151
Trade receivables, net 39,509 30,222
Prepaid expenses 648 462
Other current assets 4,224 2,544
Total current assets 86,502 44,586
Property and equipment, net 3,393 2,341
Intangible assets, net 9,353 11,276
Goodwill 16,953 17,276
Deferred tax assets   357
Other long-term assets 1,203 1,297
Total Assets 117,404 77,133
Current liabilities:    
Accounts payable 63,320 40,166
Debt for forward share purchase agreements 34,059  
Notes payable 1,716  
Notes payable due to related parties 9,414  
Deferred consideration for the acquisition   3,005
Deferred consideration for the acquisition due to related parties   3,245
Current portion of bank and other borrowings 11,243 4,686
Deferred revenue 1,397 1,500
Preference shares 683  
Preference shares due to related parties 1,847  
Payroll and payroll related accrued liabilities 1,038 1,020
Other current liabilities 1,229 1,009
Total current liabilities 125,946 54,631
Long-term portion of bank and other borrowings 16,134 9,125
Long-term portion of notes payable due to related parties 7,500  
Long-term portion of employee benefit obligation 1,398 1,147
Long-term portion of preference shares   495
Long-term portion of preference shares due to related parties   1,339
Deferred consideration for the acquisitions   1,553
Deferred consideration for the acquisitions due to related parties   1,150
Deferred tax liabilities 2,045 2,476
Other long-term liabilities 3,155 291
Total Liabilities 156,178 72,207
Commitments and contingencies (Note 20)
Stockholders’ equity (deficit):    
Preferred stock, par value of $0.0001 per share; 1,000,000 shares authorized; no shares issued or outstanding
Common stock, par value of $0.0001 per share; 100,000,000 and 11,644,561 shares authorized as of December 31, 2019 and 2018, respectively; 19,977,113 and 10,687,106 shares issued and outstanding as of December 31, 2019 and 2018, respectively [1] 2 1
Additional paid-in capital [1] 2,143 10,186
Accumulated other comprehensive income 74 31
Accumulated deficit (40,993) (5,292)
Total stockholders’ equity (deficit) (38,774) 4,926
Total liabilities and stockholders’ equity (deficit) $ 117,404 $ 77,133
[1] Amounts as of December 31, 2018 differ from those published in prior year consolidated financial statements as they were retrospectively adjusted as a result of the accounting for the Business Combination (as defined below in the notes). Specifically, the number of common shares outstanding during periods before the Business Combination are computed on the basis of the number of common shares of Kaleyra S.p.A. (accounting acquiror) during those periods multiplied by the exchange ratio established in the stock purchase agreement. Common stock and additional paid-in capital were adjusted accordingly.